Outcomes of SARS-CoV-2 Infection in Ph-neg Chronic Myeloproliferative Neoplasms: Results from the EPICOVIDEHA Registry.

Monia Marchetti,Jon Salmanton-Garcia,Shaimaa El-Ashwah,Luisa Verga,Federico Itri,Zdenek Racil,Julio Davila-Valls,Sonia Martin-Perez,Jaap Van Doesum,Francesco Passamonti,Ghaith Abu-Zeinah,Francesca Farina,Alberto Lopez-Garcia,Giulia Dragonetti,Chiara Cattaneo,Maria Gomes Da Silva,Yavuz M. Bilgin,Pavel Zak,Verena Petzer,Andreas Glenthoj,Ildefonso Espigado,Caterina Buquicchio,Valentina Bonuomo,Lucia Prezioso,Stef Meers,Rafael Duarte,Rui Bergantim,Ozren Jaksic,Natasha Colovic,Ola Blennow,Martin Cernan,Martin Schoenlein,Michail Samarkos,Maria Enza Mitra,Gabriele Magliano,Johan Maertens,Marie-Pierre Ledoux,Moraima Jimenez,Fatih Demirkan,Graham P. Collins,Alba Cabirta,Stefanie K. Graefe,Anna Nordlander,Dominik Wolf,Elena Arellano,Raul Cordoba,Michaela Hanakova,Giovanni Paolo Maria Zambrotta,Raquel Nunes Rodrigues,Giulia Limberti,Francesco Marchesi,Oliver A. Cornely,Livio Pagano

Therapeutic Advances in Hematology（2023）

Cited 2|Views60

Key words

COVID-19,essential thrombocytemia,hydroxyurea,myelofibrosis,Philadelphia-negative chronic myeloproliferative neoplasms,polycythemia vera,ruxolitinib,SARS-CoV-2

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined